Zydus Lifesciences Ltd
BSE:532321
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zydus Lifesciences Ltd
BSE:532321
|
IN |
|
Tsingtao Brewery Co Ltd
F:TSI
|
CN |
|
T
|
TAG Immobilien AG
F:TEG
|
DE |
|
Unilever Indonesia Tbk PT
F:UTG
|
ID |
|
Mercedes-Benz Group AG
SIX:MBG
|
DE |
|
MLP SE
F:MLP
|
DE |
|
K
|
Koninklijke Philips NV
SWB:PHI1
|
NL |
|
VNV Global AB (publ)
F:82K
|
SE |
|
Oracle Power PLC
F:9OC
|
UK |
Wall St Price Targets
ZYDUSLIFE Price Targets Summary
Zydus Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for ZYDUSLIFE is 1 013.71 INR with a low forecast of 801.29 INR and a high forecast of 1 365.12 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZYDUSLIFE's stock price target?
Price Target
1 013.71
INR
According to Wall Street analysts, the average 1-year price target for ZYDUSLIFE is 1 013.71 INR with a low forecast of 801.29 INR and a high forecast of 1 365.12 INR.
What is the Revenue forecast for Zydus Lifesciences Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Zydus Lifesciences Ltd?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Zydus Lifesciences Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 1%.
